Illumina, Inc.
↗San Diego, USA
Illumina is a global leader in genomics and human health, dedicated to unlocking the power of the genome. The company develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function, serving customers in research, clinical, and applied markets.
Illumina's technologies, including DNA sequencing and array-based solutions, are used by genomic research centers, pharmaceutical companies, academic institutions, and clinical laboratories worldwide. The company operates through two primary segments: Core Illumina (research and clinical sequencing) and GRAIL (early cancer detection).
CLASSIFICATION
Company Type:Diagnostics
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Genomics and Molecular Diagnostics
SIZE & FINANCIALS
Employees:5001-10000
Revenue:$4.3B
Founded:1998
Ownership:public
Status:operating
FUNDING
Total Raised:$28M
Investors:Dow Chemical Company, Lombard Odier
STOCK
Exchange:NASDAQ
Ticker:ILMN
Market Cap:$20.4B
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Technology/Diagnostics Provider)
Modalities:DNA Sequencing, Microarray
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:GRAIL
Key Partnerships:Pillar Biosciences (oncoReveal CDx partnership), Lilly (RETEVMO companion diagnostics), Bayer (VITRAKVI companion diagnostics)
COMPETITION
Position:Leader
Competitors:Quanterix, BioLife Solutions, Biocare Medical
LEADERSHIP
Key Executives:
Jacob Thaysen - President and CEO
Scientific Founders:David Walt, John Stuelpnagel, Mark Chee, Anthony Czarnik, Larry Bock
LINKS
Website:illumina.com
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Illumina, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Illumina, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.